Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 846

1.

The CD4/CD8 ratio is a prognostic factor in IgG non-responders among peptide vaccine treated ovarian cancer patients.

Waki K, Kawano K, Tsuda N, Komatsu N, Yamada A.

Cancer Sci. 2020 Feb 14. doi: 10.1111/cas.14349. [Epub ahead of print]

2.

Doxorubicin-polyglycerol-nanodiamond conjugates disrupt STAT3/IL-6-mediated reciprocal activation loop between glioblastoma cells and astrocytes.

Chen Z, Yuan SJ, Li K, Zhang Q, Li TF, An HC, Xu HZ, Yue Y, Han M, Xu YH, Komatsu N, Zhao L, Chen X.

J Control Release. 2020 Jan 24;320:469-483. doi: 10.1016/j.jconrel.2020.01.044. [Epub ahead of print]

PMID:
31987922
3.

SLAMF3-mediated signaling via ERK pathway activation promotes aggressive phenotypic behaviors in multiple myeloma.

Ishibashi M, Takahashi R, Tsubota A, Sasaki M, Handa H, Imai Y, Tanaka N, Tsukune Y, Tanosaki S, Ito S, Asayama T, Sunakawa M, Kaito Y, Kuribayashi-Hamada Y, Onodera A, Moriya K, Komatsu N, Tanaka J, Odajima T, Sugimori H, Inokuchi K, Tamura H.

Mol Cancer Res. 2020 Jan 23. pii: molcanres.0391.2019. doi: 10.1158/1541-7786.MCR-19-0391. [Epub ahead of print]

PMID:
31974290
4.

Efficient recruitment of c-FLIPL to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma.

Masuda A, Isobe Y, Sugimoto K, Yoshimori M, Arai A, Komatsu N.

Cancer Sci. 2020 Jan 6. doi: 10.1111/cas.14296. [Epub ahead of print]

5.

The role of calreticulin mutations in myeloproliferative neoplasms.

Araki M, Komatsu N.

Int J Hematol. 2020 Feb;111(2):200-205. doi: 10.1007/s12185-019-02800-0. Epub 2019 Dec 17. Review.

PMID:
31848992
6.

Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review.

Edahiro Y, Yasuda H, Ando K, Komatsu N.

Int J Hematol. 2019 Dec 9. doi: 10.1007/s12185-019-02792-x. [Epub ahead of print]

PMID:
31820325
7.

Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis.

Tsutsui M, Yasuda H, Ota Y, Komatsu N.

Case Rep Oncol. 2019 Nov 1;12(3):834-837. doi: 10.1159/000504129. eCollection 2019 Sep-Dec.

8.

Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma.

Tsukune Y, Sasaki M, Komatsu N.

Cancers (Basel). 2019 Nov 19;11(11). pii: E1819. doi: 10.3390/cancers11111819. Review.

9.

Size-controlled MoS2 nanosheet through ball milling exfoliation: parameter optimization, structural characterization and electrocatalytic application.

Tayyebi A, Ogino N, Hayashi T, Komatsu N.

Nanotechnology. 2020 Feb 7;31(7):075704. doi: 10.1088/1361-6528/ab5077. Epub 2019 Oct 23.

PMID:
31645029
10.

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.

Yuan SJ, Xu YH, Wang C, An HC, Xu HZ, Li K, Komatsu N, Zhao L, Chen X.

J Nanobiotechnology. 2019 Oct 17;17(1):110. doi: 10.1186/s12951-019-0541-8.

11.

Potential role for second‑generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.

Ishikawa M, Iriyama N, Tokuhira M, Takaku T, Sato E, Sugimoto KJ, Nakazato T, Fujita H, Kimura Y, Fujioka I, Komatsu N, Asou N, Kizaki M, Hatta Y, Kawaguchi T.

Oncol Rep. 2019 Dec;42(6):2836-2843. doi: 10.3892/or.2019.7339. Epub 2019 Sep 27.

PMID:
31578586
12.

A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA.

Kimura K, Tabe Y, Ai T, Takehara I, Fukuda H, Takahashi H, Naito T, Komatsu N, Uchihashi K, Ohsaka A.

Sci Rep. 2019 Sep 16;9(1):13385. doi: 10.1038/s41598-019-49942-z.

13.

Solving the Thermoelectric Trade-Off Problem with Metallic Carbon Nanotubes.

Ichinose Y, Yoshida A, Horiuchi K, Fukuhara K, Komatsu N, Gao W, Yomogida Y, Matsubara M, Yamamoto T, Kono J, Yanagi K.

Nano Lett. 2019 Oct 9;19(10):7370-7376. doi: 10.1021/acs.nanolett.9b03022. Epub 2019 Sep 9.

PMID:
31498635
14.

[Rapidly fatal streptococcal toxic shock syndrome due to Streptococcus agalactiae in a patient with chronic myeloid leukemia and cirrhosis].

Iizuka H, Fukuda Y, Mori Y, Iwao N, Koike M, Noguchi M, Komatsu N.

Rinsho Ketsueki. 2019;60(8):910-914. doi: 10.11406/rinketsu.60.910. Japanese.

PMID:
31484888
15.

Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface.

Masubuchi N, Araki M, Yang Y, Hayashi E, Imai M, Edahiro Y, Hironaka Y, Mizukami Y, Kihara Y, Takei H, Nudejima M, Koike M, Ohsaka A, Komatsu N.

Leukemia. 2020 Feb;34(2):499-509. doi: 10.1038/s41375-019-0564-z. Epub 2019 Aug 28.

PMID:
31462733
16.

Clumps of Mesenchymal Stem Cell/Extracellular Matrix Complexes Generated with Xeno-Free Conditions Facilitate Bone Regeneration via Direct and Indirect Osteogenesis.

Motoike S, Kajiya M, Komatsu N, Horikoshi S, Ogawa T, Sone H, Matsuda S, Ouhara K, Iwata T, Mizuno N, Fujita T, Ikeya M, Kurihara H.

Int J Mol Sci. 2019 Aug 15;20(16). pii: E3970. doi: 10.3390/ijms20163970.

17.

JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.

Inano T, Araki M, Morishita S, Imai M, Yasuda H, Nitta H, Ito M, Edahiro Y, Ochiai T, Misawa K, Fukuda Y, Ohsaka A, Komatsu N.

Br J Haematol. 2019 Oct;187(1):e27-e31. doi: 10.1111/bjh.16146. Epub 2019 Aug 16. No abstract available.

PMID:
31418453
18.

Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients.

Yasuda H, Tsutsui M, Ando J, Inano T, Noguchi M, Yahata Y, Tanaka M, Tsukune Y, Masuda A, Shirane S, Misawa K, Gotoh A, Sato E, Aritaka N, Sekiguchi Y, Sugimoto K, Komatsu N.

Int J Hematol. 2019 Nov;110(5):543-549. doi: 10.1007/s12185-019-02717-8. Epub 2019 Aug 12.

PMID:
31407257
19.

[Efficacy and safety of ruxolitinib in patients with myelofibrosis: a single-center retrospective analysis].

Edahiro Y, Komatsu N.

Rinsho Ketsueki. 2019;60(7):755-760. doi: 10.11406/rinketsu.60.755. Japanese.

PMID:
31391362
20.

Long-term eradication of extranodal NK/T cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo.

Ando M, Ando J, Yamazaki S, Ishii M, Sakiyama Y, Harada S, Honda T, Yamaguchi T, Nojima M, Ohshima K, Nakauchi H, Komatsu N.

Haematologica. 2019 Jul 11. pii: haematol.2019.223511. doi: 10.3324/haematol.2019.223511. [Epub ahead of print]

21.

Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.

Maekawa T, Kato S, Kawamura T, Takada K, Sone T, Ogata H, Saito K, Izumi T, Nagao S, Takano K, Okada Y, Tachi N, Teramoto M, Horiuchi T, Hikota-Saga R, Endo-Umeda K, Uno S, Osawa Y, Kobayashi A, Kobayashi S, Sato K, Hashimoto M, Suzu S, Usuki K, Morishita S, Araki M, Makishima M, Komatsu N, Kimura F.

Blood. 2019 Sep 5;134(10):814-825. doi: 10.1182/blood.2019000051. Epub 2019 Jul 3.

PMID:
31270105
22.

Preferential Tumor Accumulation of Polyglycerol Functionalized Nanodiamond Conjugated with Cyanine Dye Leading to Near-Infrared Fluorescence In Vivo Tumor Imaging.

Yoshino F, Amano T, Zou Y, Xu J, Kimura F, Furusho Y, Chano T, Murakami T, Zhao L, Komatsu N.

Small. 2019 Nov;15(48):e1901930. doi: 10.1002/smll.201901930. Epub 2019 Jul 1.

PMID:
31259483
23.

Chemical Functionalization of Nanodiamonds: Opportunities and Challenges Ahead.

Reina G, Zhao L, Bianco A, Komatsu N.

Angew Chem Int Ed Engl. 2019 Dec 9;58(50):17918-17929. doi: 10.1002/anie.201905997. Epub 2019 Aug 27. Review.

PMID:
31246341
24.

Malignant transformation from mature cystic teratoma of the ovary.

Shimada T, Higashijima A, Fukushima A, Komatsu N, Noguchi M, Ohashi K, Hasegawa Y, Miura K.

J Obstet Gynaecol Res. 2019 Sep;45(9):1957-1960. doi: 10.1111/jog.14043. Epub 2019 Jun 19.

PMID:
31215124
25.

MRI-based risk factors of hepatocellular carcinoma in patients with chronic liver disease: A prospective observational study.

Shimizu T, Motosugi U, Komatsu N, Ichikawa S, Inoue T, Onishi H, Enomoto N.

J Magn Reson Imaging. 2020 Feb;51(2):389-396. doi: 10.1002/jmri.26797. Epub 2019 May 23.

PMID:
31120640
26.

Hlf marks the developmental pathway for hematopoietic stem cells but not for erythro-myeloid progenitors.

Yokomizo T, Watanabe N, Umemoto T, Matsuo J, Harai R, Kihara Y, Nakamura E, Tada N, Sato T, Takaku T, Shimono A, Takizawa H, Nakagata N, Mori S, Kurokawa M, Tenen DG, Osato M, Suda T, Komatsu N.

J Exp Med. 2019 Jul 1;216(7):1599-1614. doi: 10.1084/jem.20181399. Epub 2019 May 10.

27.
28.

Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review.

Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, Tanaka R, Shimo Y, Komatsu N, Hattori N.

J Neurol. 2019 Aug;266(8):1869-1878. doi: 10.1007/s00415-019-09347-4. Epub 2019 May 2. Review.

PMID:
31049728
29.

Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44].

Gerds AT, Tauchi T, Ritchie E, Deininger M, Jamieson C, Mesa R, Heaney M, Komatsu N, Minami H, Su Y, Shaik N, Zhang X, DiRienzo C, Zeremski M, Chan G, Talpaz M.

Leuk Res. 2019 Jun;81:105. doi: 10.1016/j.leukres.2019.04.006. Epub 2019 Apr 24. No abstract available.

PMID:
31029462
30.

Single-Cell Live Imaging.

Hiratsuka T, Komatsu N.

Methods Mol Biol. 2019;1979:409-421. doi: 10.1007/978-1-4939-9240-9_24.

PMID:
31028651
31.

Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia.

De Marchi F, Araki M, Komatsu N.

Expert Rev Hematol. 2019 May;12(5):285-293. doi: 10.1080/17474086.2019.1609351. Epub 2019 Apr 27.

PMID:
30991862
32.

Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.

Edahiro Y, Araki M, Inano T, Ito M, Morishita S, Misawa K, Fukuda Y, Imai M, Ohsaka A, Komatsu N.

Eur J Haematol. 2019 Jun;102(6):516-520. doi: 10.1111/ejh.13236. Epub 2019 Apr 25.

PMID:
30977935
33.

Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis.

Iriyama N, Tokuhira M, Sato E, Sugimoto KJ, Takaku T, Ishikawa M, Nakazato T, Fujita H, Kimura Y, Fujioka I, Asou N, Komatsu N, Kizaki M, Hatta Y, Kawaguchi T.

Hematol Oncol. 2019 Aug;37(3):323-325. doi: 10.1002/hon.2617. Epub 2019 Apr 26. No abstract available.

PMID:
30950076
34.

Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy.

Fukuda Y, Araki M, Yamamoto K, Morishita S, Inano T, Misawa K, Ochiai T, Edahiro Y, Imai M, Yasuda H, Gotoh A, Ohsaka A, Komatsu N.

Haematologica. 2019 Nov;104(11):e506-e509. doi: 10.3324/haematol.2018.208876. Epub 2019 Apr 4. No abstract available.

35.

NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis.

Hayashi Y, Harada Y, Kagiyama Y, Nishikawa S, Ding Y, Imagawa J, Shingai N, Kato N, Kitaura J, Hokaiwado S, Maemoto Y, Ito A, Matsui H, Kitabayashi I, Iwama A, Komatsu N, Kitamura T, Harada H.

Blood Adv. 2019 Apr 9;3(7):1047-1060. doi: 10.1182/bloodadvances.2018025007.

36.

Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib.

Gerds AT, Tauchi T, Ritchie E, Deininger M, Jamieson C, Mesa R, Heaney M, Komatsu N, Minami H, Su Y, Shaik N, Zhang X, DiRienzo C, Zeremski M, Chan G, Talpaz M.

Leuk Res. 2019 Apr;79:38-44. doi: 10.1016/j.leukres.2019.02.012. Epub 2019 Feb 28. Erratum in: Leuk Res. 2019 Jun;81:105.

PMID:
30849661
37.

Acquired Factor VIII Inhibitor in a Patient of Rheumatoid Arthritis on Tumor Necrosis Factor Inhibitor Therapy.

Mori T, Watanabe N, Kitahara H, Iwao N, Koike M, Komatsu N.

Indian J Hematol Blood Transfus. 2019 Jan;35(1):192-193. doi: 10.1007/s12288-018-1030-1. Epub 2018 Oct 16. No abstract available.

38.

HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers.

Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N.

PLoS One. 2019 Feb 22;14(2):e0212559. doi: 10.1371/journal.pone.0212559. eCollection 2019.

39.

Size-tunable MRI-visible nitroxide-based magnetic mixed micelles: preparation, stability, and theranostic application.

Nagura K, Bogdanov A, Chumakova N, Vorobiev AK, Moronaga S, Imai H, Matsuda T, Noda Y, Maeda T, Koizumi S, Sakamoto K, Amano T, Yoshino F, Kato T, Komatsu N, Tamura R.

Nanotechnology. 2019 May 31;30(22):224002. doi: 10.1088/1361-6528/ab0627. Epub 2019 Feb 11.

PMID:
30743248
40.

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.

Hatsumi N, Miyawaki S, Yamauchi T, Takeshita A, Komatsu N, Usui N, Arai Y, Ishida F, Morii T, Kano Y, Ogura M, Machida S, Nishii K, Honda S, Ohnishi K, Naoe T; Japan Adult Leukemia Study Group (JALSG).

Int J Hematol. 2019 Apr;109(4):418-425. doi: 10.1007/s12185-019-02606-0. Epub 2019 Feb 6.

PMID:
30725360
41.

Doxorubicin conjugated with nanodiamonds and in free form commit glioblastoma cells to heterodromous fates.

Chen Z, Wang C, Li TF, Li K, Yue Y, Liu X, Xu HZ, Wen Y, Zhang Q, Han M, Komatsu N, Xu YH, Zhao L, Chen X.

Nanomedicine (Lond). 2019 Feb;14(3):335-351. doi: 10.2217/nnm-2018-0330. Epub 2019 Jan 24.

PMID:
30676239
42.

Magnetic Mixed Micelles Composed of a Non-Ionic Surfactant and Nitroxide Radicals Containing a D-Glucosamine Unit: Preparation, Stability, and Biomedical Application.

Nagura K, Takemoto Y, Yoshino F, Bogdanov A, Chumakova N, Vorobiev AK, Imai H, Matsuda T, Shimono S, Kato T, Komatsu N, Tamura R.

Pharmaceutics. 2019 Jan 19;11(1). pii: E42. doi: 10.3390/pharmaceutics11010042.

43.

Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy.

Li TF, Xu YH, Li K, Wang C, Liu X, Yue Y, Chen Z, Yuan SJ, Wen Y, Zhang Q, Han M, Komatsu N, Zhao L, Chen X.

Acta Biomater. 2019 Mar 1;86:381-394. doi: 10.1016/j.actbio.2019.01.020. Epub 2019 Jan 14.

PMID:
30654213
44.

Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes.

Komatsu N, Kajiya M, Motoike S, Takewaki M, Horikoshi S, Iwata T, Ouhara K, Takeda K, Matsuda S, Fujita T, Kurihara H.

Stem Cell Res Ther. 2018 Dec 7;9(1):342. doi: 10.1186/s13287-018-1085-9.

45.

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.

Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M.

Neuro Oncol. 2019 Feb 19;21(3):348-359. doi: 10.1093/neuonc/noy200.

46.

Mutant molecular chaperone activates cytokine receptor as a homomultimer.

Araki M, Komatsu N.

Oncotarget. 2018 Oct 16;9(81):35201-35202. doi: 10.18632/oncotarget.26221. eCollection 2018 Oct 16. No abstract available.

47.

Enteral self-expandable metal stent placement for malignant afferent limb syndrome using single-balloon enteroscope: report of five cases.

Yane K, Katanuma A, Hayashi T, Takahashi K, Kin T, Nagai K, Tanaka K, Komatsu N, Endo M, Kobayashi Y, Takigawa Y, Utsunomiya R.

Endosc Int Open. 2018 Nov;6(11):E1330-E1335. doi: 10.1055/a-0739-7640. Epub 2018 Nov 7.

48.

Clinical impact of serum soluble SLAMF7 in multiple myeloma.

Ishibashi M, Soeda S, Sasaki M, Handa H, Imai Y, Tanaka N, Tanosaki S, Ito S, Odajima T, Sugimori H, Asayama T, Sunakawa M, Kaito Y, Kinoshita R, Kuribayashi Y, Onodera A, Moriya K, Tanaka J, Tsukune Y, Komatsu N, Inokuchi K, Tamura H.

Oncotarget. 2018 Oct 5;9(78):34784-34793. doi: 10.18632/oncotarget.26196. eCollection 2018 Oct 5.

49.

Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes.

Shingai N, Harada Y, Iizuka H, Ogata Y, Doki N, Ohashi K, Hagihara M, Komatsu N, Harada H.

Int J Hematol. 2018 Dec;108(6):598-606. doi: 10.1007/s12185-018-2551-y. Epub 2018 Oct 23.

PMID:
30353274
50.

Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.

Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N.

Hepatol Res. 2019 Jan;49(1):51-63. doi: 10.1111/hepr.13277. Epub 2018 Dec 27.

PMID:
30350374

Supplemental Content

Loading ...
Support Center